SYRE Working Capital Ratio

Spyre Therapeutics Inc · Working Capital Ratio

SYRE logo

SYRE Working Capital Ratio

Latest reported92.45%
SYRE FY Working Capital Ratio (69.28% → 92.45%)
High-resolution chart · PNG

SYRE working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
92.4548%
91.114%
90.549%
66.9094%
71.6364%
82.5069%
67.497%
85.4552%
88.0254%
93.1348%
92.5208%
57.0648%
69.2843%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.